Skip to content
healthcare.dev
Get a free key

ELELYSO

NDC 0069-0106, Taliglucerase alfa, injection, powder, lyophilized, for solution, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0069-0106
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA022458
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0106 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TALIGLUCERASE ALFA200 U/5mL

Pharmacologic classes

Glucosylceramidase [CS]; Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]

Package NDCNDC-11Package
0069-0106-01000690106011 VIAL, GLASS in 1 CARTON (0069-0106-01) / 5 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fa3cbd5d-677c-4b19-9032-d9182cb69a83

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0069-0106

Use it

Look up 0069-0106 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0106 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0069-0106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.